138 related articles for article (PubMed ID: 27856637)
1. TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.
Zhao J; Liu J; Lee JF; Zhang W; Kandouz M; VanHecke GC; Chen S; Ahn YH; Lonardo F; Lee MJ
J Biol Chem; 2016 Dec; 291(53):27343-27353. PubMed ID: 27856637
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
Wille A; Weske S; von Wnuck Lipinski K; Wollnitzke P; Schröder NH; Thomas N; Nowak MK; Deister-Jonas J; Behr B; Keul P; Levkau B
J Bone Miner Res; 2024 Apr; 39(3):357-372. PubMed ID: 38477738
[TBL] [Abstract][Full Text] [Related]
3. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
Meng XM; Zhang Y; Huang XR; Ren GL; Li J; Lan HY
Oncotarget; 2015 Nov; 6(35):36984-97. PubMed ID: 26474462
[TBL] [Abstract][Full Text] [Related]
4. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
5. S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-κB and improving mitochondrial oxidative phosphorylation.
Peng J; Tang R; He J; Yu Q; Wang D; Qi D
J Transl Med; 2024 Jun; 22(1):535. PubMed ID: 38840216
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis.
Bernacchioni C; Rossi M; Vannuzzi V; Prisinzano M; Seidita I; Raeispour M; Muccilli A; Castiglione F; Bruni P; Petraglia F; Donati C
Fertil Steril; 2024 Apr; 121(4):631-641. PubMed ID: 38072366
[TBL] [Abstract][Full Text] [Related]
7. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition.
Tang PC; Chung JY; Xue VW; Xiao J; Meng XM; Huang XR; Zhou S; Chan AS; Tsang AC; Cheng AS; Lee TL; Leung KT; Lam EW; To KF; Tang PM; Lan HY
Adv Sci (Weinh); 2022 Jan; 9(1):e2101235. PubMed ID: 34791825
[TBL] [Abstract][Full Text] [Related]
8. An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer.
Sato M; Kadota M; Tang B; Yang HH; Yang YA; Shan M; Weng J; Welsh MA; Flanders KC; Nagano Y; Michalowski AM; Clifford RJ; Lee MP; Wakefield LM
Breast Cancer Res; 2014 Jun; 16(3):R57. PubMed ID: 24890385
[TBL] [Abstract][Full Text] [Related]
9. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
10. S1PR3 agonism and S1P lyase inhibition rescue mice in the severe state of experimental sepsis.
Ziegler AC; Haider RS; Hoffmann C; Gräler MH
Biomed Pharmacother; 2024 May; 174():116575. PubMed ID: 38599060
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma.
Yoneda M; Suzuki T; Nakamura T; Ajima R; Yoshida Y; Kakuta S; Katsuko S; Iwakura Y; Shibutani M; Mitsumori K; Yokota J; Yamamoto T
Cancer Sci; 2009 Feb; 100(2):225-32. PubMed ID: 19068083
[TBL] [Abstract][Full Text] [Related]
12. Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.
Daroqui CM; Ilarregui JM; Rubinstein N; Salatino M; Toscano MA; Vazquez P; Bakin A; Puricelli L; Bal de Kier Joffé E; Rabinovich GA
Cancer Immunol Immunother; 2007 Apr; 56(4):491-9. PubMed ID: 16900348
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma.
Akbari A; Amanpour S; Muhammadnejad S; Ghahremani MH; Ghaffari SH; Dehpour AR; Mobini GR; Shidfar F; Abastabar M; Khoshzaban A; Faghihloo E; Karimi A; Heidari M
Daru; 2014 Jun; 22(1):47. PubMed ID: 24902843
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal: LncRNA NEAT2 regulates oral squamous cell carcinoma progression via VEGFB and TGF-β/Smad3 pathway.
Oral Dis; 2024 Apr; 30(3):1733. PubMed ID: 36691734
[No Abstract] [Full Text] [Related]
15. Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue.
Nakamura N; Iijima T; Mase K; Furuya S; Kano J; Morishita Y; Noguchi M
Cancer Sci; 2004 Mar; 95(3):226-32. PubMed ID: 15016321
[TBL] [Abstract][Full Text] [Related]
16. Study on the interaction protein of transcription factor Smad3 based on TurboID proximity labeling technology.
Yan B; Zeng T; Liu X; Guo Y; Chen H; Guo S; Liu W
Genomics; 2024 May; 116(3):110839. PubMed ID: 38537808
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta-mediated regulation of BK virus gene expression.
Abend JR; Imperiale MJ
Virology; 2008 Aug; 378(1):6-12. PubMed ID: 18559281
[TBL] [Abstract][Full Text] [Related]
18. Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop.
Ma M; Zhuang J; Li H; Mi R; Song Y; Yang W; Lu Y; Shen X; Wu Y; Shen H
Oncogene; 2024 Jan; 43(1):47-60. PubMed ID: 37935976
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 governs muscle size through a targeted modulation of proteostasis.
Gilbert CJ; Rabolli CP; Golubeva VA; Sattler KM; Wang M; Ketabforoush A; Arnold WD; Lepper C; Accornero F
Nat Commun; 2024 Mar; 15(1):2176. PubMed ID: 38467649
[TBL] [Abstract][Full Text] [Related]
20. GGTLC1 knockdown inhibits the progression of endometrial cancer by regulating the TGF-β/Smad signaling pathway.
Tang X; Bi X; Yang A; Wang Q; Yang Y
Heliyon; 2024 Jun; 10(11):e31973. PubMed ID: 38841516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]